Streetbeat News

Acquisitions Mergers

GAIN

Gladstone Investment Corporation (NASDAQ:GAIN) has invested $18.5 million in secured first lien debt to support its equity position in Nocturne Luxury Villas through the acquisition of Grand Cayman Villas and Condos. This move aims to enhance Nocturne's portfolio with over 180 exclusive properties in Grand Cayman.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 12:50 pm

CTXR

TENK

TenX Keane shares are trading higher after shareholders approved the combination with Citius Pharma's oncology subsidiary.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 12:25 pm

NVEI

Nuvei is set to acquire Pay2All Instituição de Pagamento, enhancing its capabilities in the Brazilian market and strengthening its presence in Latin America. This acquisition marks a significant milestone in Nuvei's global expansion strategy.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 12:22 pm

ACA

Stellex Capital Management has announced a definitive agreement to acquire McConway & Torley and Standard Forged Products from Arcosa, Inc. (NYSE: ACA). The acquisition is expected to close in the third quarter. No financial terms were disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 12:14 pm

AMSC

AMSC has acquired NWL, Inc. for $25 million in cash and issued 1,297,600 restrictive shares as part of the transaction.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 12:09 pm

AMSC

AMSC (NASDAQ:AMSC) has acquired NWL, Inc. for $25 million in cash and 1,297,600 restricted shares valued at approximately $31.4 million. The acquisition aims to accelerate AMSC's growth, broaden its product offerings, and expand its market reach. NWL, which has a history of profitable revenue, supplies power components to industrial and military customers. The deal is expected to strengthen AMSC's position in the military power supply market.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 12:09 pm

CTXR

TENK

Citius Pharmaceuticals has announced that TenX Keane shareholders have approved the merger with Citius Oncology. Post-merger, Citius Pharmaceuticals will retain approximately 90% control and the new entity will trade on Nasdaq as Citius Oncology, Inc. The merger is expected to support the commercialization of LYMPHIR and exploration of additional oncology assets.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 12:06 pm

TWKS

Thoughtworks Holdings shares are trading higher after the company reported better-than-expected Q2 sales results and announced it agreed to be taken private by Apax Funds.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:52 am

ALTM

Arcadium Lithium shares are trading lower after the company announced it acquired the lithium metal business of Li-Metal Corp.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:50 am

DNB

Dun & Bradstreet (NYSE:DNB) has received inbound interest from third parties and has retained Bank of America to assist with strategic inquiries. The Board of Directors is evaluating all inquiries and strategic alternatives, but there is no assurance that any transaction will result.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 11:46 am